During 2021, a moderate growth of 14% was observed, reaching $339 million of purchases in Central America from Mexico, where the main importer in the region was Guatemala with $83 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
By 2021, there will be a reduction in the import of pharmaceutical products containing insulin at the Central American level by 44%, equivalent to $1,948 million, with Costa Rica being the main buyer with $10 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
More than 10 thousand results were observed during May 2022 in tenders under the heading "health and medicines", ranging from medical treatments to equipment and machinery used in the health sector.
An analysis by CentralAmericaData's Business Intelligence department shows interesting data on the processes that during May 2022 were published with contracts to provide pharmaceuticals, equipment and medical supplies to the several Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
The Ministry of Public Health and Social Assistance requires the acquisition of 71 different medicines to be used in the High Cost Medicines and Medical Aids Program (PMAC), which will be carried out under the Exception Purchase mechanism.
A cut-off for the first quarter of the year shows a relevant figure in the health and medicine sector for the Central American region and the Dominican Republic.
An analysis of CentralAmericaData's Business Intelligence department shows interesting data on the processes that in the first quarter of 2022 were published with contracts to supply pharmaceuticals, equipment and medical supplies to the various Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
Pharmaceutical companies need to apply location intelligence techniques and foot traffic analytics to identify consumer mobility patterns, in order to maximize sales and generate more efficient expansion models.
The correlation between foot traffic, sales, and the success of pharmacy franchises have been studied and proven, so the development of this type of analysis has become a priority in the site selection process and expansion modeling.
For the second quarter of 2021, the purchase of pharmaceutical products in the region was dominated by Costa Rica with $428 million, the largest supplier to the region was Germany with $167 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
Mobility analytics and location intelligence play an important role in business by helping to understand the behavioral patterns of consumers in any given zone of interest or point of sale.
Pedestrian flow analysis, location intelligence and point-of-interest categorization have revolutionized the way retail and wholesale industries implement expansion, commercial and operational strategies in the pharmaceutical sector.
In Nicaragua, the general procurement division of the Ministry of Health tenders the procurement of medicines, MRP and laboratories for the supply of health units with COVID-19 care.
The Guatemalan Institute of Social Security (IGSS) requires the acquisition of 9,650 linagliptin in 5 milligram coated tablets for the Gerona Medical-Surgical Specialties Outpatient Unit.
The National Oncology Institute of Panama requires a global tender for the award of the supply, storage, transportation and partial delivery of 1251 vials of Pembrolizumab 25/ML solution for intravenous infusion.
Panama Government Purchase 2021-0-12-11-08-08-LV-018937:
Between the first three months of 2020 and 2021, the imported value of pharmaceutical products in Central America registered a positive variation, going from $825 million to $866 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"].
Any data model in Big Data must be designed and developed to meet the needs of the business, and for this, it is necessary to know the objectives and goals of the organization, so that it effectively has the necessary functionalities to facilitate the decision-making process in the company.
español
2760
